DE60016209D1 - Hemisynthetisches verfahren und dessen zwischenprudukte - Google Patents

Hemisynthetisches verfahren und dessen zwischenprudukte

Info

Publication number
DE60016209D1
DE60016209D1 DE60016209T DE60016209T DE60016209D1 DE 60016209 D1 DE60016209 D1 DE 60016209D1 DE 60016209 T DE60016209 T DE 60016209T DE 60016209 T DE60016209 T DE 60016209T DE 60016209 D1 DE60016209 D1 DE 60016209D1
Authority
DE
Germany
Prior art keywords
interim products
hemisynthetic
hemisynthetic method
interim
products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60016209T
Other languages
English (en)
Other versions
DE60016209T2 (de
Inventor
Carmen Cuevas
Marta Perez
Andres Francesch
Carolina Fernandez
Jose Luis Chicharro
Pilar Gallego
Maria Zarzuelo
La Calle Fernando De
Ignacio Manzanares
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmamar SA
Original Assignee
Pharmamar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9911345.8A external-priority patent/GB9911345D0/en
Priority claimed from GBGB9918178.6A external-priority patent/GB9918178D0/en
Priority claimed from GBGB9923632.5A external-priority patent/GB9923632D0/en
Priority claimed from GB0001063A external-priority patent/GB0001063D0/en
Application filed by Pharmamar SA filed Critical Pharmamar SA
Application granted granted Critical
Publication of DE60016209D1 publication Critical patent/DE60016209D1/de
Publication of DE60016209T2 publication Critical patent/DE60016209T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
DE60016209T 1999-05-14 2000-05-15 Hemisynthetisches verfahren und dessen zwischenprudukte Expired - Lifetime DE60016209T2 (de)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GB9911345 1999-05-14
GBGB9911345.8A GB9911345D0 (de) 1999-05-14 1999-05-14
GB9918178 1999-08-02
GBGB9918178.6A GB9918178D0 (en) 2000-05-15 1999-08-02 Synthetic methods
GB9923632 1999-10-06
GBGB9923632.5A GB9923632D0 (en) 1999-10-06 1999-10-06 Hemisynthetic process towards ecteinascidin and phtalscidin compounds
GB0001063 2000-01-17
GB0001063A GB0001063D0 (en) 2000-01-17 2000-01-17 Hemisynthetic process towards ecteinascidin and phtalascidin
PCT/GB2000/001852 WO2000069862A2 (en) 1999-05-14 2000-05-15 Hemisynthetic method and intermediates thereof

Publications (2)

Publication Number Publication Date
DE60016209D1 true DE60016209D1 (de) 2004-12-30
DE60016209T2 DE60016209T2 (de) 2005-12-15

Family

ID=42632476

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60016209T Expired - Lifetime DE60016209T2 (de) 1999-05-14 2000-05-15 Hemisynthetisches verfahren und dessen zwischenprudukte

Country Status (30)

Country Link
US (3) US7241892B1 (de)
EP (1) EP1185536B1 (de)
JP (1) JP4445136B2 (de)
KR (1) KR100834601B1 (de)
CN (3) CN1229382C (de)
AR (1) AR035842A1 (de)
AT (1) ATE283273T1 (de)
AU (2) AU775580B2 (de)
BG (1) BG65896B1 (de)
BR (3) BRPI0010559B8 (de)
CA (2) CA2372058C (de)
CY (1) CY1108095T1 (de)
CZ (3) CZ303536B6 (de)
DE (1) DE60016209T2 (de)
DK (1) DK1185536T3 (de)
ES (2) ES2233367T3 (de)
HK (1) HK1047432A1 (de)
HU (1) HU230646B1 (de)
MX (1) MXPA01011631A (de)
MY (1) MY130271A (de)
NO (2) NO322016B1 (de)
NZ (1) NZ515424A (de)
PL (1) PL226890B1 (de)
PT (1) PT1185536E (de)
RU (1) RU2237063C9 (de)
SI (2) SI1185536T1 (de)
SK (2) SK287835B6 (de)
TR (1) TR200103273T2 (de)
UA (1) UA75333C2 (de)
WO (3) WO2000069862A2 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9910419A (pt) 1998-05-11 2001-01-09 Pharma Mar Sa Etm-305, etm-204, etm-775, substancialmente puros, processos para tratar leucemia de mamìferos, para tratar carcinoma de pulmão de mamìferos, para tratar adenocarcinoma de cólon de mamìferos, e para tratar melanoma maligno de mamìferos, composição farmacêutica, e, processo para testar o metabolismo citocromo humano cyp3a4 de ecteinascidina 743
MY164077A (en) 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
MY130271A (en) 1999-05-14 2007-06-29 Pharma Mar Sa Hemisynthetic method and new compounds
US7919493B2 (en) * 2000-04-12 2011-04-05 Pharma Mar, S.A. Anititumoral ecteinascidin derivatives
NZ521550A (en) * 2000-04-12 2004-10-29 Pharma Mar S Antitumoral ecteinascidin derivatives
JP4942900B2 (ja) * 2000-05-15 2012-05-30 ファルマ・マール・ソシエダード・アノニマ エクチナサイジン化合物の製造のための合成方法
US7420051B2 (en) 2000-05-15 2008-09-02 Pharma Mar, S.A. Synthetic process for the manufacture of an ecteinaschidin compound
MXPA02011319A (es) 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.
US6809099B2 (en) 2000-11-03 2004-10-26 President And Fellows Of Harvard College Saframycins, analogues and uses thereof
CN100374162C (zh) * 2000-11-06 2008-03-12 法马马有限公司 海鞘素－743在制备用于治疗肿瘤的药剂中的应用
GB0117402D0 (en) * 2001-07-17 2001-09-05 Pharma Mar Sa New antitumoral derivatives of et-743
GB0119243D0 (en) * 2001-08-07 2001-10-03 Pharma Mar Sa Antitumoral analogs of ET-743
CA2462502A1 (en) * 2001-10-19 2003-05-15 Pharma Mar, S.A. Improved use of antitumoral compound in cancer therapy
GB0202544D0 (en) * 2002-02-04 2002-03-20 Pharma Mar Sa The synthesis of naturally occuring ecteinascidins and related compounds
GB0229793D0 (en) * 2002-12-20 2003-01-29 Pharma Mar Sa The gene cluster involved in safracin biosynthesis and its uses for genetic engineering
GB0312407D0 (en) * 2003-05-29 2003-07-02 Pharma Mar Sau Treatment
US7183054B2 (en) 2003-06-03 2007-02-27 President And Fellows Of Harvard College Assay for identifying biological targets of polynucleotide-binding compounds
GB0324201D0 (en) * 2003-10-15 2003-11-19 Pharma Mar Sau Improved antitumoral combinations
PT1689404E (pt) 2003-11-13 2008-12-15 Pharma Mar Sau Combinação de et-743 com pró-fármacos de fluorouracil para o tratamento do cancro
GB0326486D0 (en) * 2003-11-14 2003-12-17 Pharma Mar Sau Combination treatment
US20080255132A1 (en) * 2003-11-14 2008-10-16 Eric Rowinsky Combination Therapy Comprising the Use of Et-743 and Paclitaxel for Treating Cancer
US20080242670A2 (en) * 2004-09-29 2008-10-02 Pharma Mar S.A., Sociedad Unipersonal Anti-Inflammatory Agents
WO2006046080A2 (en) * 2004-10-26 2006-05-04 Pharma Mar S.A., Sociedad Unipersonal Pegylated liposomal doxorubicin in combination with ecteinescidin 743
NZ554761A (en) 2004-10-29 2010-01-29 Pharma Mar Sa Formulations comprising ecteinascidin and a disaccharide
GB0522082D0 (en) * 2005-10-31 2005-12-07 Pharma Mar Sa Formulations
KR100712667B1 (ko) 2006-04-11 2007-05-02 재단법인서울대학교산학협력재단 신규한 디아자 헤테로고리 유도체 및 그의 고체상 제조방법
GB0708691D0 (en) * 2007-05-04 2007-06-13 Pharma Mar Sa Anticancer treatments a
US20090076017A1 (en) * 2007-09-15 2009-03-19 Protia, Llc Deuterium-enriched trabectedin
US20100267732A1 (en) * 2007-10-19 2010-10-21 Pharma Mar, S.A. Prognostic Molecular Markers for ET-743 Treatment
KR20110025178A (ko) * 2008-05-16 2011-03-09 파르마 마르 에스.에이. Ｐｍ00104 및 다른 항종양제를 이용한 복합 치료법
WO2009138509A1 (en) * 2008-05-16 2009-11-19 Pharma Mar, S.A. Multiple myeloma treatments
WO2011048210A1 (en) 2009-10-22 2011-04-28 Pharma Mar, S.A. PDGFR-α AS RESPONSE MARKER FOR PM00104 TREATMENT
CN107033164A (zh) * 2010-05-25 2017-08-11 法马马有限公司 制备海鞘素化合物的合成方法
ES2719091T3 (es) 2010-11-12 2019-07-08 Pharma Mar Sa Terapia de combinación con un inhibidor mitótico
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
CN107739387B (zh) * 2017-10-16 2020-01-03 上海皓元生物医药科技有限公司 一种制备曲贝替定的关键中间体化合物的方法
CN109912629B (zh) * 2017-12-13 2021-12-24 浙江中科创越药业有限公司 天然产物Trabectedin的制备
TWI824043B (zh) 2018-10-25 2023-12-01 西班牙商瑪製藥股份有限公司 藥物抗體共軛物
CN111518110B (zh) * 2019-02-01 2023-11-03 博瑞生物医药（苏州）股份有限公司 一种海鞘素化合物及其中间体的制备方法
CN111620792B (zh) * 2019-02-28 2023-01-03 兰州大学 一种n,n-二取代氰基甲酰胺的合成方法
CN116217584A (zh) * 2021-12-06 2023-06-06 南通诺泰生物医药技术有限公司 Et743及其中间体的光催化合成方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2461995A1 (fr) 1979-07-20 1981-02-06 Lcc Cice Cie Europ Compo Elect Transducteur magneto-electrique pour systeme d'enregistrement magnetique, et systeme d'enregistrement comportant un tel transducteur
JPS59225189A (ja) 1983-06-03 1984-12-18 Shionogi & Co Ltd キノナミン誘導体およびその製造法
JPS6054386A (ja) * 1983-09-02 1985-03-28 Yoshitomi Pharmaceut Ind Ltd サフラシン誘導体
JPS6084288A (ja) 1983-10-13 1985-05-13 Shionogi & Co Ltd シアノキノナミンアセテ−ト類およびその製造法
US5256663A (en) 1986-06-09 1993-10-26 The Board Of Trustees Of The University Of Illinois Compositions comprising ecteinascidins and a method of treating herpes simplex virus infections therewith
US5149804A (en) 1990-11-30 1992-09-22 The Board Of Trustees Of The University Of Illinois Ecteinascidins 736 and 722
ATE69234T1 (de) 1986-06-09 1991-11-15 Univ Illinois Ekteinascidine 729, 743, 745, 759a, 759b and 770.
US5089273A (en) 1986-06-09 1992-02-18 Board Of Trustees Of The University Of Illinois Ecteinascidins 729, 743, 745, 759A, 759B and 770
US5478932A (en) 1993-12-02 1995-12-26 The Board Of Trustees Of The University Of Illinois Ecteinascidins
US5721362A (en) 1996-09-18 1998-02-24 President And Fellows Of Harvard College Process for producing ecteinascidin compounds
US5985876A (en) 1997-04-15 1999-11-16 Univ Illinois Nucleophile substituted ecteinascidins and N-oxide ecteinascidins
EP1876180A3 (de) 1998-04-06 2009-12-16 The Board Of Trustees Of The University Of Illinois Halbsynthetische Ecteinascidine
BR9910419A (pt) 1998-05-11 2001-01-09 Pharma Mar Sa Etm-305, etm-204, etm-775, substancialmente puros, processos para tratar leucemia de mamìferos, para tratar carcinoma de pulmão de mamìferos, para tratar adenocarcinoma de cólon de mamìferos, e para tratar melanoma maligno de mamìferos, composição farmacêutica, e, processo para testar o metabolismo citocromo humano cyp3a4 de ecteinascidina 743
US6124292A (en) 1998-09-30 2000-09-26 President And Fellows Of Harvard College Synthetic analogs of ecteinascidin-743
MY130271A (en) 1999-05-14 2007-06-29 Pharma Mar Sa Hemisynthetic method and new compounds
CA2397597A1 (en) 2000-01-19 2001-07-26 The Trustees Of Columbia University In The City Of New York Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
NZ521550A (en) 2000-04-12 2004-10-29 Pharma Mar S Antitumoral ecteinascidin derivatives
MXPA02011319A (es) 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.

Also Published As

Publication number Publication date
KR100834601B1 (ko) 2008-06-02
NO20025186L (no) 2003-01-14
KR20020021636A (ko) 2002-03-21
CZ304966B6 (cs) 2015-02-18
AU4597300A (en) 2000-12-05
BRPI0110801B8 (pt) 2021-05-25
EP1185536B1 (de) 2004-11-24
ATE283273T1 (de) 2004-12-15
AU775580B2 (en) 2004-08-05
AU5649601A (en) 2001-11-26
CZ303536B6 (cs) 2012-11-21
CN1440414A (zh) 2003-09-03
WO2001087895A1 (en) 2001-11-22
SK287879B6 (sk) 2012-02-03
US7524956B2 (en) 2009-04-28
NO322016B1 (no) 2006-08-07
NO20015547L (no) 2002-01-14
BG107301A (bg) 2003-07-31
BRPI0110443B8 (pt) 2021-05-25
BG65896B1 (bg) 2010-04-30
JP2002544280A (ja) 2002-12-24
PL353002A1 (en) 2003-09-22
NZ515424A (en) 2004-06-25
MY130271A (en) 2007-06-29
UA75333C2 (uk) 2006-04-17
CA2372058A1 (en) 2000-11-23
HK1047432A1 (en) 2003-02-21
PL226890B1 (pl) 2017-09-29
CA2406095A1 (en) 2001-11-22
SI1287004T1 (sl) 2005-12-31
CZ20014102A3 (cs) 2002-06-12
BRPI0010559B8 (pt) 2021-05-25
SK16502001A3 (sk) 2002-06-04
CA2372058C (en) 2010-10-26
CZ304973B6 (cs) 2015-02-25
NO20015547D0 (no) 2001-11-13
CN1441805A (zh) 2003-09-10
TR200103273T2 (tr) 2002-04-22
CN100475822C (zh) 2009-04-08
BRPI0110801B1 (pt) 2018-02-27
RU2237063C2 (ru) 2004-09-27
BR0110443A (pt) 2003-04-08
ES2233367T3 (es) 2005-06-16
CY1108095T1 (el) 2014-02-12
CZ20023751A3 (en) 2004-05-12
MXPA01011631A (es) 2002-07-30
DK1185536T3 (da) 2005-04-04
US20080045713A1 (en) 2008-02-21
DE60016209T2 (de) 2005-12-15
CN1360588A (zh) 2002-07-24
SI1185536T1 (en) 2005-06-30
WO2001087894A1 (en) 2001-11-22
HUP0201188A2 (en) 2002-07-29
AR035842A1 (es) 2004-07-21
BR0010559A (pt) 2002-07-02
BRPI0110443B1 (pt) 2018-06-26
JP4445136B2 (ja) 2010-04-07
CN1229382C (zh) 2005-11-30
CA2406095C (en) 2010-02-16
CN1211386C (zh) 2005-07-20
PT1185536E (pt) 2005-04-29
WO2000069862A3 (en) 2001-03-22
BRPI0010559B1 (pt) 2016-08-30
US7241892B1 (en) 2007-07-10
HU230646B1 (hu) 2017-05-29
EP1185536A2 (de) 2002-03-13
ES2231486T3 (es) 2005-05-16
US20040002602A1 (en) 2004-01-01
NO328301B1 (no) 2010-01-25
BR0110801A (pt) 2003-02-11
CZ20023746A3 (cs) 2003-04-16
WO2000069862A2 (en) 2000-11-23
RU2237063C9 (ru) 2008-10-10
SK15272002A3 (sk) 2003-06-03
NO20025186D0 (no) 2002-10-29
SK287835B6 (sk) 2011-12-05

Similar Documents

Publication Publication Date Title
DE60016209D1 (de) Hemisynthetisches verfahren und dessen zwischenprudukte
DE69834401D1 (de) Businterfacesystem und verfahren
DE60027698D1 (de) Lasttragendes osteoimplantat und verfahren zu seiner herstellung
DE60026034D1 (de) Zusammendrückbeständiges mikriporöses material und verfahren zu seiner herstellung
ATE379971T1 (de) Disinfektionsmittel und verfahren zu dessen herstellung
DE60039438D1 (de) Elektrostatischer ultraschallwandler und verfahren zu dessen herstellung
DE59810418D1 (de) Aufgeweiteter stent und verfahren zum herstellen desselben
DE69838230D1 (de) Frequenzumsetzer und verfahren
DE60013027D1 (de) Bauteil und Verfahren zu seiner Herstellung
DE69913180D1 (de) Extraktionseinheiten und verfahren
DE69823540D1 (de) Sterilisationsverpackung und verfahren
DE69942382D1 (de) Sensor und verfahren zu dessen herstellung
DE60018049D1 (de) Ionisationsstab und verfahren zu dessen herstellung
ATE555078T1 (de) Verfahren und zwischenprodukte
DE69901135T2 (de) Tiegel und verfahren zu seiner herstellung
ATE286658T1 (de) Teigformmaschine und verfahren
DE60019627D1 (de) Ferrofluid-zusammensetzung und verfahren
DE59912840D1 (de) Elektromagnetischer durchflussmesser und verfahren zu seiner herstellung
DE50010354D1 (de) Verbundteil und verfahren zu dessen herstellung
DE69939280D1 (de) Sende-Empfänger und Verfahren
DE69905326T2 (de) Sollerschlitz und Verfahren zu dessen Herstellung
ATA75297A (de) Dekorlaminat und verfahren zu seiner herstellung
ATA139199A (de) Bauelement und verfahren zu dessen herstellung
DE50005895D1 (de) Transportsicherung und verfahren zum herstellen derselben
DE69524527D1 (de) AIDS-hemmende Arzneizubereitung und Verfahren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition